Loading clinical trials...
Loading clinical trials...
This 39-week, open label study is designed to assess long-term efficacy, safety and tolerability of lumiracoxib 100mg od in patients with osteoarthritis (OA) of the knee who participated in the 13-wee...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis
NCT07551245 · Knee Arthritis Osteoarthritis
NCT06702046 · Osteoarthritis (OA) of the Knee
NCT07217405 · Osteoarthritis Hand, Osteoarthritis Wrist
NCT06755697 · Knee Osteoarthritis, Glucose, and more
NCT05986292 · Osteoarthritis, Knee, Diabetic Neuropathic Pain, and more
Tucson, Arizona
Brooklyn Park, Minnesota
Albuquerque, New Mexico
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions